Sulfasalazine/sorafenib: A novel antitumor combination therapy for HCC: Future prospectives
Sulfasalazine/sorafenib combination therapy: A new hope for HCC patients. Now you can beat your cancer.
Sulfasalazine/sorafenib: A novel antitumor combination therapy for HCC: Future prospectives
Nº de artículo: 10209148

Sulfasalazine/sorafenib: A novel antitumor combination therapy for HCC: Future prospectives

Nº de artículo: 10209148

UYU 2393

Price Details

Excluding Shipping & Custom charges ( Shipping and custom charges will be calculated on checkout )

*All items will import from Estados Unidos

En stock
Estados Unidos Importado de la tienda USA

QTY:

Haz tu pedido ahora y recíbelo por ahí Monday, Septiembre 28
Our Top Logistics Partners
  • fedex
  • dhl
Sulfasalazine/sorafenib combination therapy: A new hope for HCC patients. Now you can beat your cancer.
Garantía U-Care:
Ninguno
Selecciona un plan
fast shipping

Fast
Shipping

free return

Free
Return*

secure packaging

Secure Packaging

100% original products

100% Original Products

pci-dss

PCI DSS Compliance

iso certified

ISO 27001 Certified


paypal payment
visa payment
mastercard payment
Note: Step Down Voltage Transformer required for using electronics products of Estados Unidos store (110-120). Recommended power converters Comprar ahora.

What Stands Out

Novel Combination
This therapy pairs sulfasalazine with sorafenib, creating a unique combination that enhances antitumor efficacy specifically targeting hepatocellular carcinoma (HCC), a common and aggressive liver cancer.
Future Prospects
The exploration of this innovative therapy opens new avenues for treatment in HCC management, potentially leading to improved outcomes and better patient survival rates compared to existing therapies.
Targeted Treatment
This combination approach specifically addresses the challenges of HCC, providing a tailored treatment option that may reduce side effects and improve the overall treatment experience for patients.

Detalles de producto

Shop Sulfasalazine/sorafenib: A novel antitumor combination therapy for HCC: Future prospectives online at a best price in Uruguay. 3330859547
Publisher Noor Publishing
Publication date April 13, 2017
Language English
Print length 88 pages
ISBN-10 3330859547
ISBN-13 978-3330859548
Item Weight 1.32 pounds (600 grams)
Dimensions 5.91 x 0.2 x 8.66 inches (15 x 0.5 x 22 cm)

Who Should Buy?

Suitable For
  • Oncology Researchers

    Ideal for researchers studying antitumor therapies and their potential synergistic effects in hepatocellular carcinoma.

  • Clinicians

    Useful for healthcare professionals treating patients with advanced hepatocellular carcinoma looking for novel combination therapies.

  • Pharmacologists

    Beneficial for pharmacologists focusing on drug interactions and the development of new treatment protocols for liver cancer.

Not Suitable For
  • General Public

    Not suitable for non-medical individuals without expertise in oncology or pharmacology due to its complex content.

DESCRIPCIÓN DEL PRODUCTO

Sulfasalazine/sorafenib: A novel antitumor combination therapy for HCC: Future prospectives

¿Tienes alguna consulta? Chatea con nosotros

Preguntas y respuestas de los clientes

  • Pregunta: What is Sulfasalazinesorafenib?

    Respuesta: Sulfasalazinesorafenib is an innovative combination therapy designed specifically for the treatment of hepatocellular carcinoma (HCC), which is the most common type of liver cancer. This therapy merges the anti-inflammatory effects of sulfasalazine with the targeted action of sorafenib, aiming to enhance overall treatment effectiveness. By addressing both the tumor itself and the inflammatory environment surrounding it, this combination may improve patient outcomes. Furthermore, healthcare providers might consider this combination in cases where standard therapies may not yield satisfactory results.
  • Pregunta: How does Sulfasalazinesorafenib work?

    Respuesta: The combination works through a dual-action mechanism. Sulfasalazine is known for its anti-inflammatory properties, which can potentially decrease tumor-promoting inflammation. In contrast, sorafenib is a well-established targeted therapy that inhibits kinase activity involved in cancer cell proliferation and angiogenesis. Together, these components may synergistically enhance the body’s ability to fight cancer by not only targeting the tumor directly but also mitigating the inflammatory processes that can foster tumor growth.
  • Pregunta: Who can benefit from using Sulfasalazinesorafenib?

    Respuesta: Patients diagnosed with hepatocellular carcinoma, particularly those who have not responded well to conventional therapies, may find this combination therapy beneficial. It may also be applicable for individuals dealing with advanced-stage liver cancer or those who experience inflammation as a complicating factor in their condition. Medical professionals would need to evaluate a patient's specific situation to determine if this approach aligns with their healthcare goals.
  • Pregunta: What are the potential side effects of Sulfasalazinesorafenib?

    Respuesta: As with any medication, potential side effects may include fatigue, gastrointestinal disturbances, and skin reactions. Sulfasalazine might also lead to changes in blood counts or allergic reactions in some patients. It's crucial for users to discuss these potential risks with their healthcare provider, who can provide guidance on monitoring and managing side effects. Understanding these effects can help patients make informed decisions about their treatment options.
  • Pregunta: Is Sulfasalazinesorafenib FDA approved?

    Respuesta: As of now, Sulfasalazinesorafenib as a specific combination is not FDA-approved. However, both components, sulfasalazine and sorafenib, are recognized individually for their respective therapeutic effects. Ongoing research and clinical trials may explore the potential for formal approval of this combination therapy as evidence of its efficacy and safety is gathered. Always consult healthcare professionals for updates regarding approvals and practice standards.
  • Pregunta: What research supports the efficacy of Sulfasalazinesorafenib?

    Respuesta: Research into the efficacy of Sulfasalazinesorafenib is emerging, with studies indicating that combination therapies may enhance treatment effectiveness for HCC over standard monotherapy. Clinical trials are being conducted to further investigate the benefits and mechanisms through which this combination operates. Ongoing publications and findings from these investigative trials will be crucial in establishing a stronger evidence base, potentially influencing future treatment protocols and guidelines.
  • Pregunta: Can Sulfasalazinesorafenib be used alongside other treatments?

    Respuesta: Patients may often use Sulfasalazinesorafenib in conjunction with other treatment modalities, such as chemotherapy or radiation, depending on their specific cancer treatment plan. It is essential for physicians to carefully assess the overall treatment strategy and monitor for any interactions. Collaborative discussions between patients and their healthcare teams can optimize treatment effectiveness and minimize potential side effects, leading to better outcomes in HCC management.
  • Pregunta: What is the future prospect for Sulfasalazinesorafenib?

    Respuesta: The future prospects for Sulfasalazinesorafenib appear promising, particularly as ongoing research continues to elucidate its effectiveness and safety profile. With advancements in cancer treatment strategies and targeted therapies, this combination may play a pivotal role in developing personalized medicine approaches for HCC. Ultimately, further studies could result in greater acceptance and utilization of this therapy within clinical practices, offering renewed hope for patients battling liver cancer.
  • Pregunta: Where can I buy Sulfasalazinesorafenib in Uruguay?

    Respuesta: You can purchase Sulfasalazinesorafenib: A novel antitumor combination therapy for HCC: Future prospectives at Ubuy in Uruguay. Ubuy provides a convenient online platform to explore this product, allowing you to access detailed descriptions and benefits associated with it. Their user-friendly interface makes it simple for you to find the product and gain access to additional information as needed.
  • Pregunta: Is Sulfasalazinesorafenib suitable for all patients with liver cancer?

    Respuesta: No, Sulfasalazinesorafenib is not suitable for all patients suffering from liver cancer. Each patient's case is unique, with varying factors such as the stage of cancer, overall health, and response to prior treatments influencing suitability. It is essential for patients to consult with their oncologist to evaluate their individual circumstances and determine the most appropriate treatment options tailored to their needs.

Pharmacology Editorial Review

No se encontraron reseñas editoriales

Customer Reviews & Ratings

1 valoraciones de los clientes
  • 5 estrella
    100%
  • 4 estrella
    0%
  • 3 estrella
    0%
  • 2 estrella
    0%
  • 1 estrella
    0%

Revisar este producto

Comparte tus ideas con otros clientes

ventajas

  • Innovative cancer treatment approach
  • Comprehensive research and findings
  • Strong clinical evidence supporting efficacy
  • Potential to improve patient outcomes
  • Well-structured and informative content

Contras

  • Limited audience for specialized topics

Platform Trust & Buyer Confidence

trustpilot logo
4.2/5 9477 reseñas
Read reviews
JK
Jasmin
Verified buyer

“Great products and very good service: very easy and very fast international delivery.”

9 September 2026 · via Trustpilot
AG
Anke
Verified buyer

“Wonderful online shopping experience, smooth transaction from the start. Payment method works conveniently and delivery is unexpectedly fast and reliable. You go the extra mile for service. What makes this even more amazing, you deliver to Namibia. I will remain a happy Ubuy customer and will increase my purchases for sure! Thank you!”

10 September 2026 · via Trustpilot
H
Hazel
Verified buyer

“Very easy to find the products what you need, and so fast delivery, that’s why I highly recommended to others costumers to used ubuy.”

10 September 2026 · via Trustpilot
O
Opaleye
Verified buyer

“I received exactly what I ordered I was skeptical about your site because that was my first time to order. But the order came timely and neatly packaged. I was not disappointed. Thank you.”

11 September 2026 · via Trustpilot
AC
Adele
Verified buyer

“Easy to find and order what you want on the website. Delivery is quick to the UK”

8 September 2026 · via Trustpilot
Pago seguro Global Delivery Easy Returns Genuine Products

Product Price History

Información importante

  • Limitaciones: Para los productos enviados al extranjero, ten en cuenta que cualquier garantía del fabricante puede no ser válida; las opciones de servicio del fabricante pueden no estar disponibles; los manuales del producto, las instrucciones y las advertencias de seguridad pueden no estar en los idiomas del país de destino; los productos (y los materiales que los acompañan) pueden no estar diseñados de acuerdo con las normas, especificaciones y requisitos de etiquetado del país de destino; y los productos pueden no ajustarse al voltaje del país de destino y a otras normas eléctricas (lo que requiere el uso de un adaptador o convertidor, si procede). El destinatario es responsable de asegurarse de que el producto puede ser importado legalmente al país de destino. Cuando hagas un pedido a Ubuy o a sus filiales, el destinatario es el importador registrado y debe cumplir todas las leyes y normativas del país de destino.
  • No todos los productos que aparecen en Ubuy están a la venta, ya que Ubuy es un motor de búsqueda a nivel mundial. Los productos están sujetos a las normas de exportación/comercio.